NAMRU-6 is seeking to purchase laboratory reagents to be used for molecular diagnosis of Mayaro virus, Alphaviruses (Venezuelan equine encephalitis virus (VEEV), Western equine encephalitis virus (WEEV), Eastern equine encephalitis virus (EEEV), Mayaro virus (MAYV), Una virus (UNAV), Trocara virus (TROCV)) RNA, Oropouche virus, Arenavirus (Tacaribe virus new world), and Dengue virus in the Virology & Emerging Infections Department. Specifically, requirement involves PCR enzymes for reverse transcription and real-time platforms that are used for detection of Mayaro nucleic acid from serum, whole blood, tissue, infected mosquitoes, and cell culture via RT and PCR (SOP N6-VIR-MB ARB 007); detection of Alphavirus RNA using a molecular method in two steps from serum, whole blood, autopsy tissue, infected mosquitoes pools and mosquito cell culture (SOP N6-VIR-MB ARB 008); identify Oropouche RNA from serum, whole blood, autopsy tissue, and infected mosquitoes pools, and mosquito cell culture (SOP N6-VIR-MB ARB 009); screening to identify Arenavirus mew world viruses RNA from serum, whole blood, autopsy tissue, and infected mosquitoes pools, and mosquito cell culture (N6-VIR-MB ARB 011); and, discrimination and identification of the four serotype of dengue virus (Den 1, Den 2, Den 3 and Den 4) RNA from serum, whole blood, autopsy tissue, and infected mosquitoes pools, and mosquito cell culture (N6-VIR-MB ARB 015).
All these NAMRU-6 assays have been validated using the TaqMan 7500/7500 Fast Real time PCR system and therefore, compatibility of the consumables is a requirement. The RT-PCR assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Reagents used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to be initiated from zero, which would delay all processing and the timely diagnosis of public health relevant pathogens.
This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 12:00 PM Local Time, 30 August, 2016. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: [email protected]. Please use subject line "VEI16137THERMOFISHER".
Contracting Office Address:
3230 Lima Pl, Washington DC, 20521
United States

Primary Point of Contact.:
Martin Vasquez
[email protected]

Bid Protests Not Available